Leveraging personalized circulating tumor DNA monitoring to predict treatment response and recurrence in high-risk endometrial cancer

被引：0
|
作者：
Pham, Melissa [1 ]
Scalise, Carly Bess [2 ]
Kalashnikova, Ekaterina [2 ]
Dutta, Punashi [2 ]
Chen, Xi [3 ]
Narcisse, Subrina [1 ]
Rangel, Kelly [1 ]
Urbauer, Diana [3 ]
Elnaggar, Adam [2 ]
Westin, Shannon [1 ]
Jazaeri, Amir [1 ]
Lu, Karen [1 ]
Soliman, Pamela [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med, Houston, TX USA
[2] Natera Inc, Translat Med, Austin, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期
关键词：
D O I：
10.1136/ijgc-2023-IGCS.251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP159
引用
收藏
页码：A141 / A141
页数：1
相关论文
共 50 条
  • [21] Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence
    Yoo, Tae-Kyung Robyn
    Lee, Ji-Young
    Park, Hwan
    Cho, Whi-Kyung
    Jeon, Seyeon
    Jun, Ha Ra
    Lee, Sae Byul
    Chung, Il Yong
    Kim, Hee Jeong
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Ahn, Sei-Hyun
    Jeong, Jae Ho
    Kim, Jeong Eun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Sung-Bae
    Lee, Hee Jin
    Gong, Gyungyub
    Kim, Jisun
    Chun, Sung-Min
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] Deep sequencing of circulating tumor DNA for personalized lung cancer detection and radiotherapy response monitoring
    Diehn, Maximilian
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S3 - S3
  • [23] Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers
    Bellone, Stefania
    McNamara, Blair
    Mutlu, Levent
    Demirkiran, Cem
    Hartwich, Tobias Max Philipp
    Harold, Justin
    Yang-Hartwich, Yang
    Siegel, Eric R.
    Santin, Alessandro D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [24] Evaluation of circulating tumor DNA in patients with endometrial cancer harboring somatic PIK3CA or KRAS mutations: A potential high-risk factor for recurrence
    Shintani, D.
    Hihara, T.
    Ogasawara, A.
    Yabuno, A.
    Fujiwara, K.
    Tai, K.
    Hasegawa, K.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 36 - 37
  • [25] Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
    Coombes, Raoul Charles
    Page, Karen
    Salari, Raheleh
    Hastings, Robert K.
    Armstrong, Anne
    Ahmed, Samreen
    Ali, Simak
    Cleator, Susan
    Kenny, Laura
    Stebbing, Justin
    Rutherford, Mark
    Sethi, Himanshu
    Boydell, Anna
    Swenerton, Ryan
    Fernandez-Garcia, Daniel
    Gleason, Kelly L. T.
    Goddard, Katie
    Guttery, David S.
    Assaf, Zoe J.
    Wu, Hsin-Ta
    Natarajan, Prashanthi
    Moore, David A.
    Primrose, Lindsay
    Dashner, Scott
    Tin, Antony S.
    Balcioglu, Mustafa
    Srinivasan, Ramya
    Shchegrova, Svetlana V.
    Olson, Alexander
    Hafez, Dina
    Billings, Paul
    Aleshin, Alexey
    Rehman, Farah
    Toghill, Bradley J.
    Hills, Allison
    Louie, Maggie C.
    Lin, Cheng-Ho Jimmy
    Zimmermann, Bernhard G.
    Shaw, Jaqueline A.
    CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4255 - 4263
  • [26] Deep sequencing of circulating tumor DNA for personalized cancer detection and monitoring
    Diehn, Maximilian
    ANNALS OF ONCOLOGY, 2015, 26 : 3 - 3
  • [27] Circulating tumor DNA (ctDNA) testing for recurrence and treatment response monitoring in hepatocellular carcinoma (HCC)
    Abdelrahim, M.
    Mejia, A.
    Esmail, A.
    Ouf, M.
    Franses, J. W.
    Bhan, I.
    Sudha, K.
    Brdiges, C.
    Tin, T.
    Brewer, C.
    Aushev, V.
    Palsuledesai, C. C.
    Jurdi, A.
    Liu, M. C.
    Ghobrial, R. M.
    He, A. R.
    ANNALS OF ONCOLOGY, 2024, 35 : S82 - S82
  • [28] Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer
    Grassi, Tommaso
    Harris, Faye R.
    Smadbeck, James B.
    Murphy, Stephen J.
    Block, Matthew S.
    Multinu, Francesco
    Klein, Janet L. Schaefer
    Zhang, Piyan
    Karagouga, Giannoula
    Liu, Minetta C.
    Larish, Alyssa
    Lemens, Maureen A.
    Sommerfield, Marla Kay S.
    Cappuccio, Serena
    Cheville, John C.
    Vasmatzis, George
    Mariani, Andrea
    PLOS ONE, 2021, 16 (06):
  • [29] Serial circulating tumor DNA (ctDNA) monitoring to predict response to treatment in metastatic gastrointestinal cancers
    Parikh, A.
    Kanter, K.
    Mojtahed, A.
    Schneider, J.
    Van Seventer, E.
    Fish, M.
    Allen, J.
    Blaszkowsky, L.
    Wo, J.
    Clark, J.
    Giantonio, B.
    Goyal, L.
    Hong, T.
    Nipp, R.
    Roeland, E.
    Weekes, C.
    Zhu, A.
    Ryan, D.
    Fetter, I.
    Horick, N.
    Corcoran, R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Circulating Tumor DNA in the Monitoring of Soft Tissue Sarcoma Treatment and Recurrence
    Sun, Beatrice J.
    Li, Amy Y.
    Hur, Dong G.
    Zhou, Maggie
    Poultsides, George A.
    Delitto, Daniel J.
    Lee, Byrne
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 7682 - 7684
12345